SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-030285
Filing Date
2018-11-29
Accepted
2018-11-29 16:41:04
Documents
5
Period of Report
2018-11-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K phas-8k_20181127.htm 8-K 34392
2 EX-99.1 phas-ex991_6.htm EX-99.1 210045
3 EX-99.2 phas-ex992_33.htm EX-99.2 14325
4 GRAPHIC gbqwqciutpvu000001.jpg GRAPHIC 710846
5 GRAPHIC gd5ptcbb2lzw000001.jpg GRAPHIC 710846
  Complete submission text file 0001564590-18-030285.txt   2218661
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 181208893
SIC: 2834 Pharmaceutical Preparations